PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 108 filers reported holding PULMONX CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,000 | +14.6% | 4,592 | +48.5% | 0.00% | – |
| Q2 2023 | $41,000 | +95.2% | 3,092 | +61.3% | 0.00% | – |
| Q1 2023 | $21,000 | -59.6% | 1,917 | -69.1% | 0.00% | – |
| Q4 2022 | $52,000 | +642.9% | 6,198 | +1386.3% | 0.00% | – |
| Q3 2022 | $7,000 | +133.3% | 417 | +117.2% | 0.00% | – |
| Q2 2022 | $3,000 | -92.5% | 192 | -88.0% | 0.00% | – |
| Q1 2022 | $40,000 | -77.4% | 1,605 | -70.9% | 0.00% | – |
| Q4 2021 | $177,000 | +90.3% | 5,517 | +114.3% | 0.00% | – |
| Q3 2021 | $93,000 | +14.8% | 2,575 | +40.0% | 0.00% | – |
| Q2 2021 | $81,000 | +102.5% | 1,839 | +113.1% | 0.00% | – |
| Q1 2021 | $40,000 | +48.1% | 863 | +119.0% | 0.00% | – |
| Q4 2020 | $27,000 | – | 394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |